| Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE (NCT07722780) | Vigonvita Life Sciences | 2026-08-31 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets (NCT07710326) | Vigonvita Life Sciences | 2026-08-01 |
| Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults (NCT07703956) | Vigonvita Life Sciences | 2026-07-31 |
| Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers (NCT07565792) | Vigonvita Life Sciences | 2026-05-11 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules (NCT07507838) | Vigonvita Life Sciences | 2026-04-13 |
| Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants (NCT07372703) | Vigonvita Life Sciences | 2026-01-29 |
| Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers (NCT07302269) | Vigonvita Life Sciences | 2026-01-04 |
| Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers (NCT07240636) | Vigonvita Life Sciences | 2025-11-28 |
| A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension (NCT06749236) | Vigonvita Life Sciences | 2025-08-11 |
| Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD (NCT06828887) | Vigonvita Life Sciences | 2025-04-03 |
| Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 (NCT06504290) | Vigonvita Life Sciences | 2024-07-16 |
| A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET (NCT06476509) | Vigonvita Life Sciences | 2024-05-30 |
| Long-term Safety of TPN171H Tablet in Erectile Dysfunction. (NCT06301854) | Vigonvita Life Sciences | 2024-04-12 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension (NCT06328400) | Vigonvita Life Sciences | 2024-03-27 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules (NCT06279533) | Vigonvita Life Sciences | 2024-02-27 |
| A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV (NCT06206720) | Vigonvita Life Sciences | 2024-01-31 |
| Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers (NCT06105151) | Vigonvita Life Sciences | 2023-10-27 |
| Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers (NCT06070857) | Vigonvita Life Sciences | 2023-10-05 |
| A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension (NCT05932459) | Vigonvita Life Sciences | 2023-07-09 |
| Effect of TPN171H on Spermatogenesis (NCT05585931) | Vigonvita Life Sciences | 2022-11-15 |
| Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers (NCT05750355) | Vigonvita Life Sciences | 2022-10-10 |
| Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction (NCT05388825) | Vigonvita Life Sciences | 2022-08-01 |
| Efficacy and Safety of JT001 (VV116) Compared With Paxlovid (NCT05341609) | Vigonvita Life Sciences | 2022-04-04 |
| A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects (NCT05208814) | Vigonvita Life Sciences | 2022-03-31 |
| Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. (NCT05188989) | Vigonvita Life Sciences | 2021-12-31 |
| Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers (NCT05221138) | Vigonvita Life Sciences | 2021-12-30 |
| Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function (NCT05185011) | Vigonvita Life Sciences | 2021-12-16 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers (NCT05201690) | Vigonvita Life Sciences | 2021-12-14 |
| Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers (NCT05227768) | Vigonvita Life Sciences | 2021-11-11 |
| Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects (NCT04655872) | Vigonvita Life Sciences | 2020-11-26 |
| Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension (NCT04483115) | Vigonvita Life Sciences | 2020-11-16 |
| Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects (NCT06090136) | Vigonvita Life Sciences | 2020-09-14 |
| Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction (NCT04479917) | Vigonvita Life Sciences | 2020-07-23 |
| Drug-Drug Interaction (DDI) Study for TPN171H (NCT06090123) | Vigonvita Life Sciences | 2020-01-01 |